Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison. (Q48210350)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

title

Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

main subject

chronic myeloid leukemia

0 references

0 references

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Kristin M Phillips

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Javier Pinilla-Ibarz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Eduardo Sotomayor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Heather S L Jim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Lubomir Sokol

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Jeffrey Lancet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Sara Tinsley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Kendra Sweet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Rami Komrokji

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

20 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

Supportive Care in Cancer

18 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

1097-1103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

18 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

Assessment of quality of life with imatinib mesylate as first-line treatment in chronic phase-chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

Tyrosine kinase inhibitors: the first decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia: Definitions and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

The Italian SF-36 Health Survey: translation, validation and norming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

Fatigue after treatment for early stage breast cancer: a controlled comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

Identifying clinically meaningful fatigue with the Fatigue Symptom Inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

Psychometric evaluation of the Pittsburgh Sleep Quality Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

The memorial symptom assessment scale short form (MSAS-SF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1630-5

10.1007/S00520-012-1630-5

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json

release_sq3zzasfunbaxakzkxmie52b64

18 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sq3zzasfunbaxakzkxmie52b64

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179489%20AND%20SRC:MED&resulttype=core&format=json